Home › Galena Biopharma Earns "Buy" Rating from Roth Capital
 

Keywords :   


Galena Biopharma Earns "Buy" Rating from Roth Capital

2015-05-24 06:48:06| Biotech - Topix.net

's stock had its "buy" rating reiterated by equities researchers at Roth Capital in a research report issued on Friday. They currently have a $8.00 price target on the biotechnology company's stock.

Tags: buy rating capital roth

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Forecast Discussion Number 35
07.07Tropical Storm Beryl Wind Speed Probabilities Number 35
07.07Tropical Storm Beryl Public Advisory Number 35
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Tropical Storm Beryl Forecast Advisory Number 35
07.07Tropical Storm Beryl Public Advisory Number 34A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
More »